Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-24
DOI
10.3389/fonc.2019.00945
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of CD137 expression by viral genes reduces T cell costimulation
- (2019) Meihui Wu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hodgkin lymphoma cell lines: to separate the wheat from the chaff
- (2018) Hans G. Drexler et al. BIOLOGICAL CHEMISTRY
- Trogocytosis of ligand-receptor complex and its intracellular transport in CD30 signalling
- (2018) Makoto Nakashima et al. BIOLOGY OF THE CELL
- Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
- (2017) C A van der Weyden et al. Blood Cancer Journal
- Targeting Immune System Alterations in Hodgkin Lymphoma
- (2017) Natalie S. Grover et al. Current Hematologic Malignancy Reports
- Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma
- (2016) R. Chen et al. BLOOD
- Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
- (2016) Donatella Aldinucci et al. CANCER LETTERS
- CD137 signaling in Hodgkin and Reed-Sternberg cell lines induces IL-13 secretion, immune deviation and enhanced growth
- (2016) Sakthi Rajendran et al. OncoImmunology
- Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
- (2015) Ingrid Glimelius et al. AMERICAN JOURNAL OF HEMATOLOGY
- A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
- (2014) Angeline XH Goh et al. mAbs
- Finding a needle in a haystack
- (2014) Qunrui Ye et al. OncoImmunology
- CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas
- (2012) Matthew W. Anderson et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression of CD137 on Hodgkin and Reed-Sternberg Cells Inhibits T-cell Activation by Eliminating CD137 Ligand Expression
- (2012) W. T. Ho et al. CANCER RESEARCH
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- How I treat relapsed and refractory Hodgkin lymphoma
- (2011) J. Kuruvilla et al. BLOOD
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
- (2011) W. Schaefer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started